Introduction
Autoimmune diseases
Autoantibodies - Introduction
Autoantibodies - Determination
 
Autoantibodies
Rheumatoid Factor
Antinuclear Antibodies (ANA)
Specific Antibodies
Anti-neutrophil Cytoplasmic Antibodies
(ANCA)
Anti-phospholipid Antibodies
Anti-mitochondrial Antibodies (AMA)
Anti-endothelial Cell Antibodies (AECA)
Anti CCP antibodies
Antibodies against DNases
 
Quality Assurance
 
Reference ranges
 
Algorithm
ANA and incidence of diseases
Proposed stepwise diagnosis scheme
Positive Immunoflourescence -
Nucleoplasmic
Positive Immunoflourescence - Nucleolar
Positive Immunoflourescence -
Cytoplasmic
Type of autoimmune diseases
Conditions associated with antinuclear
antibodies (ANA)
 
Slide show
 
References
 
Collaborators
Anti CCP antibodies - Introduction


Citrulline is an unusual amino acid resulting from an enzymatically posttranslationally modified arginine residue. Citrulline is present on a few human proteins, including filaggrin. Recently, a an enzyme-linked immunosorbent assay (ELISA) was developed, to detect autoantibodies against a cyclic variant of a citrullinated peptide (CCP) (197).

Anti-CCP antibodies are reported to be significant predictors of RA and to useful for the (early) diagnosis of RA (198 – 202).

Citrulline antibody is an antibody that binds to a non-standard amino acid (citrulline) that is formed by removing amino groups from the natural amino acid, arginine.
Research suggests that in the joints of patients with rheumated arthrits, proteins may be changed to citrulline as part of the process that leads to inflammation of the rheumatoid joint. Citrulline antibody has also been referred to as anti-citrulline antibody, anti-cyclic citrullinated peptide antibody, and anti-CCP